HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business (Wellness)

Set Alert for Business {Wellness}

Deals

Set Alert for Deals {Wellness}

Latest From Wellness & Deals

Dermapharm Expands Natural Offering With France's Arkopharma

Germany's Dermapharm will pay €450m to acquire herbal specialist Arkopharma to expand its footprint in Europe's consumer health market in countries such as France, Spain and Italy.

Deals Europe

GSK Exits Consumer Health With Haleon Launch

The global market leader in consumer health is now Haleon following its separation from GSK after more than two years of planning.

Business Strategies Deals

Mayoly Spindler Enhances Natural Supplements Offering With Pharm Nature

France's Mayoly Spindler is expanding its offering in its local dietary supplements market by acquiring Pharm Nature Micronutrition which specializes in natural products based on organic ingredients.

France Deals
See All

Strategy

Set Alert for Business Strategy {Wellness}

Latest From Wellness & Business Strategies

ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach

Vision Healthcare’s Sensilab pulled Facebook advertisements for its weight loss supplements after UK regulator the Advertising Standards Authority launched an investigation into whether the marketing, which featured slim models, was "irresponsible." 

Ad Complaints United Kingdom

DSM Overcomes Supply Chain Challenges To Post First-Half Sales Gain

Heerlen, Netherlands-based DSM posted a double-digit rise in sales at its Health, Nutrition and Care operation in the first half despite facing a "continuous battle" to place and receive deliveries.

Sales & Earnings Dietary Supplements

House Members Object To Senate Adding Supplement MPL Proposal In FDA User Fee Bill

Members led by SC Republican Jeff Duncan and CA Democrat Tony Cárdenas, in letter to House speaker and minority leader, oppose MPL provision in latest version of S.4348 for re-authorizing FDA drug, biologic and medical device user fee programs.

Dietary Supplements FDA
See All

Sales & Earnings

Set Alert for Sales & Earnings {Wellness}

Latest From Wellness & Sales & Earnings

DSM Overcomes Supply Chain Challenges To Post First-Half Sales Gain

Heerlen, Netherlands-based DSM posted a double-digit rise in sales at its Health, Nutrition and Care operation in the first half despite facing a "continuous battle" to place and receive deliveries.

Sales & Earnings Dietary Supplements

Inflation, Supply Chain And Private Label Pressures: Consumer Health Leaders Talk ‘Big Picture’ Challenges

OTC drug and dietary supplement companies continue to face significant economic and competitive issues in what continues to be a highly volatile operating environment. Here we’ve culled takes from top execs at Sanofi, Bayer, J&J, P&G and other leading players, provided during recent sales and earnings presentations.

Business Strategies Supply Chain

Perrigo Starts Supply Chain Overhaul After Filing OTC Birth Control NDA, Launching Nasonex Switch

Along with Q2 results including reported net sales up 14.3% to $1.12bn, Perrigo announces overhaul of its supply chain expected to generate $100m to $300m in net cost savings and creation of women's health, skin care business units.

Sales & Earnings Supply Chain
See All

Litigation

Set Alert for Legal Issues

Latest From Wellness & Legal Issues

First Recalls, Now Investors' Concerns Over Ranitidine Litigation Take Pharmas For Wild Ride

Host of complaints in US courts, seeking damages or alleging ranitidine caused various cancers, followed FDA’s 2020 findings of NDMA levels exceeding allowable limits in some samples provoked  Litigation is starting to come to trial, the first set for 22 August in Illinois and a bellwether case due to begin in California in February 2023.

Recalls OTC Drugs

If US Court Says Delta-8 Product Is Lawful And Trademark Valid, Will Federal Agencies Listen?

Recent 9th Circuit ruling upheld granting a firm preliminary injunction stopping competitor from using its trademarked brand for delta-8 THC products. Ruling generally runs counter to USPTO policy against accepting trademark registrations for hemp or cannabis products and specifically counters FDA stance delta-8 doesn’t meet definition of hemp under 2018 farm bill.

Cannabidiol CBD Legal Issues

CBD Will Be US FDA’s ‘One’ Lawful Hemp Compound, House Appropriators Anticipate

Reference in report accompanying House Appropriation Committee bill for FDA FY2023 budget isn’t binding and wasn’t appropriators’ first mention of agency’s response to de-scheduling hemp as a controlled substance. But their ’ statement was more pointed than in previous appropriation reports.

Cannabidiol CBD FDA
See All
UsernamePublicRestriction

Register